What is the IQVIA Holdings Inc. stock price forecast?

IQVIA Holdings Inc. is currently trading at $179.17. View real-time AI analysis on Alpha Lenz.

What is IQVIA Holdings Inc. insider trading activity?

View the latest insider trading data for IQVIA Holdings Inc. on Alpha Lenz.

What is IQVIA Holdings Inc.'s P/E ratio?

IQVIA Holdings Inc.'s P/E ratio is 22.6.

IQVIA Holdings Inc.

NYSE · IQV

$179.17+0.78(+0.44%)Pre-market

Ask about IQVIA Holdings Inc.'s future dividend policy...

Alpha Chat Insight

“IQVIA Holdings Inc. trades at a P/E of 22.6 (fair value) with strong ROE of 21.6%.”

Ask for details →

Company Overview

IQVIA Holdings Inc. is a leading global provider of technology solutions, advanced analytics, and clinical research services, primarily serving the life sciences and healthcare industries. The company plays a critical role in supporting pharmaceutical, biotechnology, and medical device organizations across the continuum of drug development, from early-stage clinical trials (Phase I–IV) to post-market analysis. IQVIA’s operations are organized into three main segments: Technology & Analytics Solutions, which delivers cloud-based applications, healthcare data management, and consulting; Research & Development Solutions, which offers comprehensive contract research services for clinical trials; and Contract Sales & Medical Solutions, focused on commercial outsourcing and patient engagement. Its vast database covers anonymized health records from over one billion individuals globally, empowering clients to generate real-world evidence and make informed decisions that drive innovation and improve patient outcomes. With a workforce of nearly 90,000 employees in over 100 countries, IQVIA is recognized for its domain expertise, global reach, and role in accelerating healthcare transformation through connected intelligence and next-generation technology.

CEOMr. Ari Bousbib

Websitehttps://www.iqvia.com

SectorHealthcare

IndustryDiagnostics & Research

Employees90,000

Company Statistics

FY 2025

Profile

$30.80BMarket Cap

$16.31BRevenue

0.00Shares Out

90,000Employees

Margins

33.29%Gross

21.92%EBITDA

14.02%Operating

9.75%Pre-Tax

8.34%Net

Valuation

22.65P/E

4.74P/B

1.89EV/Sales

12.56EV/EBITDA

15.02P/FCF

Growth (CAGR)

4.21%Rev 3Yr

7.50%Rev 5Yr

7.77%Op Inc 3Yr

23.91%Op Inc 5Yr

7.65%Net Inc 3Yr

34.61%Net Inc 5Yr

Returns

4.79%ROA

21.64%ROE

8.16%ROIC

Financial Health

$1.98BCash & Cash Equivalents

$21.33BNet Debt

351.64%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“IQVIA Holdings Inc. trades at a P/E of 22.6 (fair value) with strong ROE of 21.6%.”

Ask for details →

Frequently Asked Questions

IQVIA Holdings Inc. (ticker: IQV) is a company listed on NYSE in the Healthcare sector (Diagnostics & Research). It has approximately 90,000 employees. Market cap is $30.8B.

The current price is $179.17 with a P/E ratio of 22.65x and P/B of 4.74x.

ROE is 21.64% and operating margin is 14.02%. Annual revenue is $16.3B.